ImageneBio, Inc.
IMA
$5.51
-$0.04-0.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -74.74% | -43.56% | -678.48% | -21.19% | 72.77% |
| Total Depreciation and Amortization | 117.50% | 496.81% | 106.67% | -85.49% | -88.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 396.57% | 200.00% | 1,080.81% | -- | -98.75% |
| Change in Net Operating Assets | -271.02% | -170.38% | -1,173.23% | -1,574.91% | 8.15% |
| Cash from Operations | -104.70% | -107.71% | -694.35% | -99.25% | 21.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1,424.27% | -612.08% | -- | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -22.22% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18,116.67% | 100.00% | -- | -- | -- |
| Cash from Financing | -12,114.81% | -100.00% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -60.00% | 485.84% | 85.71% | -96.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.72% | -346.29% | 5,734.63% | 118.19% | -766.05% |